Clinical Trial Update: A Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma Patients [Phase 2]

View source ↗

Summary

This is an update on a Phase 2 clinical trial evaluating valganciclovir in patients with glioblastoma; the study (NCT04116411) is currently active but not recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Valcyte (valganciclovir)

Snippet

Sponsor: Cecilia Soderberg-Naucler | Conditions: Glioblastoma Multiforme | Phase 2 | Status: ACTIVE_NOT_RECRUITING